NCT07114159Recruiting
Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
An Open-label Clinical Trial to Evaluate the Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
Source: ClinicalTrials.gov · Last updated 11 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Although the incidence of inflammatory bowel disease is stable in North American and European countries, the incidence of inflammatory bowel disease is increasing in newly industrialized countries, especially in China. The treatment drugs for ulcerative colitis include 5-aminosalicylic acid (5-ASA), glucocorticoids, immunosuppressants, and biological agents. The aim of this clinical trial is to evaluate the long-term safety and efficacy of sacral nerve stimulation in patients with ulcerative colitis
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 4 Aug 2025
- Start date
- 2 Aug 2025
- Primary completion date
- 1 Dec 2032
- Lead sponsor
- Xijing Hospital
- Diseases
- Ulcerative colitis
- NCT number
- NCT07114159
What you commit to
- Study type: Interventional
- Planned participants: 15
- From 2 Aug 2025 to the primary completion date, 1 Dec 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment-naive ulcerative colitis (no previous treatment)
- Currently taking any biologicals
- Previous surgical treatment or severe colitis at imminent risk of surgery
Other illness
- Other systemic diseases
Other
- Acute severe ulcerative colitis
- infective colitis
- Pregnancy and lactation
Who the study is looking for
- age 18-65 years
- ulcerative colitis diagnosed for at least 3 mouths.
- Mayo score 6-12, Mayo endoscopic score 2-3 points
- resistant to medical treatment
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xijing hospital Coordinator of this site? Confirm its status | Xi'an | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.